Clinical Trial Update: A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489 [Phase 2]

View source ↗

Summary

A Phase 2 study to evaluate PF-07868489 in people with pulmonary arterial hypertension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• PF-07868489

Snippet

Sponsor: Pfizer | Conditions: Pulmonary Hypertension | Phase 2 | Status: RECRUITING